{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-252203","form_type":"8-K","ticker":"DBVT","cik":"0001613780","company_name":"DBV Technologies S.A.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.984831+00:00","generated_at":"2026-05-30T04:34:32.762284+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"DBV Technologies reports Q3 cash $46.4M; going concern doubt, cash runway into Q1 2025","bullets":["Net loss of $90.9M for 9M ended Sep 30 2024 vs $61.5M prior year; Q3 net loss $30.4M.","Cash and cash equivalents $46.4M as of Sep 30 2024, down from $141.4M at Dec 31 2023.","Operating cash burn $92.2M in 9M 2024; company expects cash to fund ops only into Q1 2025.","Substantial doubt about ability to continue as going concern; seeks additional capital.","R&D expenses surged to $70.4M in 9M 2024 ($47.4M prior year) driven by VITESSE Phase 3 trial."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-252203","json":"https://secwatch.observer/filing/0001193125-24-252203.json","markdown":"https://secwatch.observer/filing/0001193125-24-252203.md","text":"https://secwatch.observer/filing/0001193125-24-252203.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613780/000119312524252203/0001193125-24-252203-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613780/000119312524252203/d866460d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:34:32.762284+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}